Overview
Myalgic encephalomyelitis (ME) is characterized by chronic fatigue and neurological symptoms, often overlapping with presentations seen in Long Covid 1. It can manifest with diverse neurological complications, including optic perineuritis post-vaccination and associations with thyrotoxicosis 24.Diagnosis
Clinical diagnosis challenging without evidence of infection; consider clinical criteria when laboratory evidence is lacking 3.
Evaluate for unexplained optic neuropathy and neurological deficits post-vaccination or in association with endocrine disorders 24.
Laboratory tests may lack definitive markers; clinical presentation remains crucial 3.Management
No specific first-line treatments universally recommended; management often symptom-focused 3.
Adjunctive therapies may include symptomatic relief measures (e.g., pain management, cognitive behavioral therapy) tailored to individual symptoms 3.
Thyrotoxicosis-related encephalomyelitis improved with antithyroid medications like Tapazole 4.Special Populations
Thyrotoxicosis: Neurological symptoms improved with treatment of hyperthyroidism using Tapazole 4.
Vaccination: Consider encephalomyelitis with bilateral optic perineuritis as a potential complication post-influenza vaccination, warranting thorough neurological evaluation 2.Key Recommendations
Approach diagnosis cautiously, relying heavily on clinical presentation due to limited laboratory markers (Evidence: Moderate 3).
Investigate unexplained optic neuropathy and neurological symptoms following vaccinations for potential encephalomyelitis 2 (Evidence: Weak).
In cases associated with thyrotoxicosis, managing hyperthyroidism can lead to neurological improvement 4 (Evidence: Weak).References
1 Marshall-Gradisnik S, Eaton-Fitch N. Understanding myalgic encephalomyelitis. Science (New York, N.Y.) 2022. link
2 Vilain S, Waterschoot MP, Mavroudakis N. Encephalomyelitis and bilateral optic perineuritis after influenza vaccination. Bulletin de la Societe belge d'ophtalmologie 2000. link
3 Zala J. Diagnosing myalgic encephalomyelitis. The Practitioner 1989. link
4 Bassi S, Albizzati MG, Beltramelli A, Frattola L. Encephalomyelitis with thyrotoxicosis. Journal of neurology 1978. link
5 Cole FE, Pedersen CE, Robinson DM, Eddy GA. Improved method for production of attenuated Venezuelan equine encephalomyelitis (TC-83 strain) vaccine. Journal of clinical microbiology 1976. link